Report overview
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
This report contains market size and forecasts of Pediatric Drugs and Vaccines in global, including the following market information:
Global Pediatric Drugs and Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pediatric Drugs and Vaccines Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Pediatric Drugs and Vaccines companies in 2021 (%)
The global Pediatric Drugs and Vaccines market was valued at 98250 million in 2021 and is projected to reach US$ 175610 million by 2028, at a CAGR of 8.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diphtheria Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pediatric Drugs and Vaccines include Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA) and Actelion Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pediatric Drugs and Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric Drugs and Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pediatric Drugs and Vaccines Market Segment Percentages, by Type, 2021 (%)
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Global Pediatric Drugs and Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pediatric Drugs and Vaccines Market Segment Percentages, by Application, 2021 (%)
Newborn
Infant
Child
Global Pediatric Drugs and Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pediatric Drugs and Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatric Drugs and Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pediatric Drugs and Vaccines revenues share in global market, 2021 (%)
Key companies Pediatric Drugs and Vaccines sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Pediatric Drugs and Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
